Trial intelligence / Profile preview

Evaluation of the intraluminal behaviour of fenofibrate in healthy volunteers

2013-003815-23Phase 4Completed

Sponsor
KU Leuven
Start
Nov 2013
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, open-label trial of fenofibrate in hyperlipidemia (3 arms), sponsored by KU Leuven. Started Nov 2013; status: completed.

02

Drugs

fenofibrate
03

Conditions

hyperlipidemia

Beyond the preview

Go deeper on 2013-003815-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003815-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call